Teladoc finance chief to step down
Mala Murthy, who has served as CFO of the telehealth company since 2019, will leave the position next month for an opportunity outside the healthcare industry.
Mala Murthy, who has served as CFO of the telehealth company since 2019, will leave the position next month for an opportunity outside the healthcare industry.
Of the 25 companies receiving tax incentives in Massachusetts, 23 will add jobs outside of Boston and Cambridge. Medtronic, which is receiving the largest award, will create 220 roles in Billerica. Other recipients include AbbVie, Dyne Therapeutics and Viridian Therapeutics.
$17M in Tax Incentives Will Add 800 Life Sciences Jobs This Year in Massachusetts Read More »
Lawmakers called for more transparency about how hospitals are using 340B revenue, including audits of participating facilities.
Senators show bipartisan support for reforming 340B during HELP hearing Read More »
The cornerstone of the deal is Ixo-vec, an intravitreal gene therapy currently in Phase III development for wet age-related macular degeneration. Eli Lilly made another foray into genetic medicine in June, picking up Verve Therapeutics for up to $1.3 billion.
Lilly Dives Deeper Into Gene Therapy With up to $262M Adverum Buy Read More »
The Appalachian system said it is turning to the courts as a last resort after failing to resolve years of payment and patient care issues.
Ballad Health sues UnitedHealth for Medicare Advantage ‘manipulation’ Read More »
The antibody-drug conjugate, withdrawn from the market by GSK in 2022 after failing a confirmatory study, was approved Thursday by the FDA for previously treated patients with multiple myeloma. This is despite a negative advisory committee vote in July.
GSK’s Blenrep Makes Comeback With FDA Nod for Third-Line Multiple Myeloma Read More »
Sales of Sanofi’s COVID-19 and flu vaccines fell 17% in the third quarter amid declining vaccination rates and pricing pressures in Europe.
Sanofi’s Legacy Vaccine Sales Decline As Americans Skip Flu Shots Read More »
The discontinued CAR T therapy bbT369 came to Regeneron when the pharma bought all of 2seventy bio’s pipeline assets for $5 million upfront in January 2024.
Regeneron Cans 2seventy-Acquired CAR T Candidate for Lymphoma in ‘Strategic’ Move Read More »
In three draft guidance documents, the FDA has laid out pointers to help companies craft better drug development programs and drug applications.
La alimentación y la producción agrícola están cada vez más en el centro de los debates globales, un mundo en el que la historia del químico finlandés Artturi Ilmari Virtanen (1895-1973) adquiere una renovada relevancia. Su labor —que culmin …
Artturi Ilmari Virtanen: el químico finlandés que revolucionó la nutrición agraria Read More »